Skip to main content
All lobbying filings

ACADEMY OF MANAGED CARE PHARMACY

ACADEMY OF MANAGED CARE PHARMACY filed a Q2 report for ACADEMY OF MANAGED CARE PHARMACY on July 28, 2025.

Lobbying for ACADEMY OF MANAGED CARE PHARMACY · Professional association representing managed care pharmacy

All filings by ACADEMY OF MANAGED CARE PHARMACY · Everything ACADEMY OF MANAGED CARE PHARMACY has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 28, 2025
Expenses
$170,000
What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding

Pharmacy

Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem